Diltiazem Hydrochloride In Sodium Chloride Injection, Solution
Product Images NDC 44567-663

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Diltiazem Hydrochloride In Sodium Chloride (NDC 44567-663). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wg Critical Care, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Image (Image 01)

FDA Label Image

Diltiazem HCl In 0.72% Sodium Chloride Injection 100 mg Per 100 mL Bag Image (Image 02)

Diltiazem HCl In 0.72% Sodium Chloride Injection 100 mg Per 100 mL Bag Image (Image 02)
This is a medication label for Diltiazem Hydrochloride solution containing 100 mg per 100 mL in 0.72% Sodium Chloride Injection. It is for intravenous use only and should not be used in series connections. The recommended storage temperature is between 2°C to 6°C to protect from freezing. The product should be used within 28 days of removal from the overwrap. It is manufactured in Switzerland for WG Critical Care, LLC in Paramus, NJ.*
FDA Label Image

Diltiazem HCl In 0.72% Sodium Chloride Injection 250 mg Per 250 mL Bag Image (Image 03)

Diltiazem HCl In 0.72% Sodium Chloride Injection 250 mg Per 250 mL Bag Image (Image 03)
This text is a description of a medication containing Diltiazem Hydrochloride in Sodium Chloride Injection for intravenous use. Each 250 mL bag contains 250 mg of Diltiazem Hydrochloride. It is important to check for leaks and solution clarity before administration and discard if leaks are found. The recommended storage conditions are refrigerated at 2°C to 8°C to protect from freezing. The product must be used within 28 days of removal from its overwrap. The medication is manufactured by WG Critical Care, LLC in Switzerland. It also provides instructions about the lot number, expiration date, and UPC details.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.